Past Podcast Episodes

In today's special episode of RealTalk MS, Dr. Michael Kornberg is going to give us a glimpse into emerging research and the future of MS treatments. So, if you'd like a preview of the new MS therapies that will be available to you, this is the conversation you're looking for.

Dr. Michael Kornberg

Dr. Kornberg is an Assistant Professor of Neurology at the Johns Hopkins University School of Medicine and, in addition to his clinical work, Dr. Kornberg's lab is focused on identifying novel therapeutic strategies to prevent neurodegeneration and promote remyelination in MS.

During our conversation, we'll try to cover all the therapeutic bases, from predicting MS progression to a whole new class of drugs to treat MS. From stem cell therapy to remyelination.

We have a lot to talk about! Are you ready for RealTalk MS??!

Congrats to the winner of the $100 Amazon gift card! :51

Dr. Michael Kornberg discusses emerging MS research and next-generation MS therapies 2:25

Share this episode 36:20

Have a minute? Leave a rating & review for the podcast 36:40

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/192

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 192
Guests: Dr. Michael Kornberg

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS

Privacy Policy

With 200 million Americans having already received their COVID-19 vaccination, public health officials are warning that vaccine hesitancy is a growing challenge to our nation's ability to fully bounce back from the pandemic and resume something resembling the life we once knew.

Dr. Dorlan Kimbrough

If what you're seeing and hearing about the COVID vaccines on social media or from well-meaning friends and family is making you nervous, my guest, Dr. Dorlan Kimbrough, is joining me to set the record straight.

Dr. Kimbrough is a member of the National MS Society's COVID Vaccine Guidance Task Force and we're talking about vaccine side effects among people living with MS, vaccine interactions with MS disease-modifying therapies, and other information that you should know before you go for your vaccination.

We're also talking about new progressive MS research that's about to be funded by the International Progressive MS Alliance.

We're sharing the good news about a DMT that's just been approved for people living with relapsing-remitting MS in England and Wales.

And we'll share some of the research that was discussed last week at the American Academy of Neurology 2021 Annual Meeting.

We have a lot to talk about! Are you ready for RealTalk MS??!

International Progressive MS Alliance reviews research award applications 2:50

Kesimpta approved for RRMS in England and Wales 3:38

News from the AAN 2021 Annual Meeting 4:32

Dr. Dorlan Kimbrough discusses what you need to know about COVID-19 vaccines and MS 10:36

Share this episode 30:02

Have a minute? Leave a rating & review for the podcast 30:22